EE200200625A - Orto-asendatud antraniilhappeamiidid ja nende kasutamine ravimitena - Google Patents

Orto-asendatud antraniilhappeamiidid ja nende kasutamine ravimitena

Info

Publication number: EE200200625A
Authority: EE; Estonia
Prior art keywords: acid amides; anthranilic acid; orthosubstituted; medicaments; ortho
Prior art date: 2000-05-09

Application number

EEP200200625A

Other languages

English (en)

Inventor

Krger Martin

Huth Andreas

Petrov Orlin

Seidelmann Dieter

Thierauch Karl-Heinz

Haberey Martin

Menrad Andreas

Ernst Alexander

Original Assignee

Schering Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-09

Filing date

2001-05-08

Publication date

2004-04-15

2001-05-08 Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft

2004-04-15 Publication of EE200200625A publication Critical patent/EE200200625A/et

2007-12-17 Publication of EE04938B1 publication Critical patent/EE04938B1/et

Links

PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical class NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
230000033115 angiogenesis Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002085 persistent effect Effects 0.000 abstract 1
239000008177 pharmaceutical agent Substances 0.000 abstract 1
230000001960 triggered effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Diabetes (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Gastroenterology & Hepatology (AREA)
Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

EEP200200625A 2000-05-09 2001-05-08 Orto-asendatud antraniilhappeamiidid ja nende kasutamine ravimitena EE04938B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10023486A DE10023486C1 (de)	2000-05-09	2000-05-09	Ortho substituierte Anthranilsäureamide und deren Verwendung als Arzneimittel
PCT/EP2001/005214 WO2001085719A1 (de)	2000-05-09	2001-05-08	Ortho substituierte anthranilsäureamide und deren verwendung als arzneimittel

Publications (2)

Publication Number	Publication Date
EE200200625A true EE200200625A (et)	2004-04-15
EE04938B1 EE04938B1 (et)	2007-12-17

Family

ID=7641923

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200625A EE04938B1 (et)	2000-05-09	2001-05-08	Orto-asendatud antraniilhappeamiidid ja nende kasutamine ravimitena

Country Status (30)

Country	Link
US (2)	US7081468B2 (et)
EP (1)	EP1280799B1 (et)
JP (1)	JP2003532725A (et)
KR (1)	KR20020094024A (et)
CN (1)	CN1237062C (et)
AT (1)	ATE258174T1 (et)
AU (2)	AU7400101A (et)
BG (1)	BG107261A (et)
BR (1)	BR0110621A (et)
CA (1)	CA2407852A1 (et)
CZ (1)	CZ20023677A3 (et)
DE (2)	DE10023486C1 (et)
DK (1)	DK1280799T3 (et)
EE (1)	EE04938B1 (et)
ES (1)	ES2214424T3 (et)
HR (1)	HRP20020977B1 (et)
HU (1)	HUP0301954A2 (et)
IL (2)	IL152578A0 (et)
MX (1)	MXPA02010915A (et)
NO (1)	NO323541B1 (et)
NZ (1)	NZ521700A (et)
PL (1)	PL358204A1 (et)
PT (1)	PT1280799E (et)
RU (1)	RU2264399C2 (et)
SK (1)	SK15882002A3 (et)
TR (1)	TR200400912T4 (et)
UA (1)	UA73187C2 (et)
WO (1)	WO2001085719A1 (et)
YU (1)	YU82702A (et)
ZA (1)	ZA200209896B (et)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10023484A1 (de) *	2000-05-09	2001-11-22	Schering Ag	Anthranylamide und deren Verwendung als Arzneimittel
DE10023486C1 (de) *	2000-05-09	2002-03-14	Schering Ag	Ortho substituierte Anthranilsäureamide und deren Verwendung als Arzneimittel
US6878714B2 (en) *	2001-01-12	2005-04-12	Amgen Inc.	Substituted alkylamine derivatives and methods of use
US20030134836A1 (en) *	2001-01-12	2003-07-17	Amgen Inc.	Substituted arylamine derivatives and methods of use
US7102009B2 (en)	2001-01-12	2006-09-05	Amgen Inc.	Substituted amine derivatives and methods of use
US7105682B2 (en) *	2001-01-12	2006-09-12	Amgen Inc.	Substituted amine derivatives and methods of use
US6995162B2 (en)	2001-01-12	2006-02-07	Amgen Inc.	Substituted alkylamine derivatives and methods of use
TW200306819A (en) *	2002-01-25	2003-12-01	Vertex Pharma	Indazole compounds useful as protein kinase inhibitors
US7307088B2 (en) *	2002-07-09	2007-12-11	Amgen Inc.	Substituted anthranilic amide derivatives and methods of use
AU2003281855A1 (en) *	2002-07-31	2004-02-23	Schering Aktiengesellschaft	Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
US7615565B2 (en)	2002-07-31	2009-11-10	Bayer Schering Pharma Aktiengesellschaft	VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
US20050004133A1 (en) *	2003-06-05	2005-01-06	Makings Lewis R.	Modulators of VR1 receptor
US7202260B2 (en)	2003-06-13	2007-04-10	Schering Ag	VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
DE10327719A1 (de) *	2003-06-13	2005-01-20	Schering Ag	VEGFR-2 und VEGFR-3 Inhibitorische Anthranylamidpyridone
WO2005030776A1 (en)	2003-09-23	2005-04-07	Vertex Pharmaceuticals Incorporated	Pyrazolopyrrole derivatives as protein kinase inhibitors
DE102004009238A1 (de) *	2004-02-26	2005-09-08	Merck Patent Gmbh	Arylamid-Derivate
US7427390B2 (en) *	2004-03-10	2008-09-23	Schering Ag	Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
DE102004011720B4 (de) *	2004-03-10	2008-04-03	Bayer Schering Pharma Aktiengesellschaft	Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie
US7906533B2 (en)	2004-11-03	2011-03-15	Bayer Schering Pharma Ag	Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
EP1655295A1 (en)	2004-11-03	2006-05-10	Schering Aktiengesellschaft	Anthranilamide pyridinureas as VEGF receptor kinase inhibitors
EP1657241A1 (en)	2004-11-03	2006-05-17	Schering Aktiengesellschaft	Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors
US8247556B2 (en)	2005-10-21	2012-08-21	Amgen Inc.	Method for preparing 6-substituted-7-aza-indoles
BRPI0619208A2 (pt) *	2005-11-30	2011-09-20	Astellas Pharma Inc	derivado de 2-aminobenzamida c07d 307/14 c07d 307/22 c07d 309/14 c07d 319/12 c07d 401/12 c07d 405/12 c07d 413/12 c07d 417/12
IL311677B2 (en)	2014-01-13	2025-06-01	Aurigene Oncology Ltd	Bicyclic heterocyclyl derivatives as irak4 inhibitors
CA2952188A1 (en) *	2014-06-20	2015-12-23	Aurigene Discovery Technologies Limited	Substituted indazole compounds as irak4 inhibitors
CN120267671A (zh)	2017-03-31	2025-07-08	奥锐金肿瘤有限公司	用于治疗血液病的化合物和组合物
EP4410377A3 (en)	2017-10-31	2024-11-13	Curis, Inc.	Compounds and compositions for treating hematological disorders
CA3214747A1 (en)	2021-04-08	2022-10-13	Reinhard Von Roemeling	Combination therapies for the treatment of cancer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3409668A (en) *	1964-11-07	1968-11-05	Palazzo Giuseppe	Substituted anthranilamides and process for the preparation thereof
RU2024507C1 (ru) *	1991-11-18	1994-12-15	Евгений Яковлевич Левитин	5-хлор-2-пиридиламид-4-нитро-n-(карбоксиметил)антраниловой кислоты, проявляющий противовоспалительную активность
FR2689508B1 (fr) *	1992-04-01	1994-06-17	Fournier Ind & Sante	Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.
GB9824579D0 (en) *	1998-11-10	1999-01-06	Novartis Ag	Organic compounds
UA71587C2 (uk) *	1998-11-10	2004-12-15	Шерінг Акцієнгезелльшафт	Аміди антранілової кислоти та їхнє застосування як лікарських засобів
DE10023492A1 (de) *	2000-05-09	2001-11-22	Schering Ag	Aza- und Polyazanthranylamide und deren Verwendung als Arzneimittel
DE10023486C1 (de) *	2000-05-09	2002-03-14	Schering Ag	Ortho substituierte Anthranilsäureamide und deren Verwendung als Arzneimittel
DE10023484A1 (de) *	2000-05-09	2001-11-22	Schering Ag	Anthranylamide und deren Verwendung als Arzneimittel
DE50213703D1 (de) *	2001-05-08	2009-09-03	Bayer Schering Pharma Ag	Selektive anthranylamidpyridinamide als vegfr-2 und vegfr-3 inhibitoren
US20040039019A1 (en) *	2002-06-19	2004-02-26	Schering Ag	Selected anthranilaminde pyridinamides and their use as pharmaceutical agents
US7517894B2 (en) *	2002-07-31	2009-04-14	Bayer Schering Pharma Ag	VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
US7615565B2 (en) *	2002-07-31	2009-11-10	Bayer Schering Pharma Aktiengesellschaft	VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
US7202260B2 (en) *	2003-06-13	2007-04-10	Schering Ag	VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
JP2008506773A (ja) *	2004-07-19	2008-03-06	ティアメディカアクスイェセルスカプ	タンパク質材料と非酸化性脂肪酸体を含む組成物
US7906533B2 (en) *	2004-11-03	2011-03-15	Bayer Schering Pharma Ag	Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
EP1655295A1 (en) *	2004-11-03	2006-05-10	Schering Aktiengesellschaft	Anthranilamide pyridinureas as VEGF receptor kinase inhibitors
EP1657241A1 (en) *	2004-11-03	2006-05-17	Schering Aktiengesellschaft	Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors
US20060266770A1 (en) *	2005-05-26	2006-11-30	Fitzgerald Robert M	Portable dispensers comprising a mobile dispenser and mobile storage cartridge

2000
- 2000-05-09 DE DE10023486A patent/DE10023486C1/de not_active Expired - Fee Related
2001
- 2001-05-08 BR BR0110621-0A patent/BR0110621A/pt not_active IP Right Cessation
- 2001-05-08 KR KR1020027014966A patent/KR20020094024A/ko not_active Abandoned
- 2001-05-08 MX MXPA02010915A patent/MXPA02010915A/es active IP Right Grant
- 2001-05-08 YU YU82702A patent/YU82702A/sh unknown
- 2001-05-08 AT AT01940416T patent/ATE258174T1/de not_active IP Right Cessation
- 2001-05-08 IL IL15257801A patent/IL152578A0/xx unknown
- 2001-05-08 HU HU0301954A patent/HUP0301954A2/hu unknown
- 2001-05-08 PT PT01940416T patent/PT1280799E/pt unknown
- 2001-05-08 CZ CZ20023677A patent/CZ20023677A3/cs unknown
- 2001-05-08 CA CA002407852A patent/CA2407852A1/en not_active Abandoned
- 2001-05-08 US US10/275,480 patent/US7081468B2/en not_active Expired - Fee Related
- 2001-05-08 ES ES01940416T patent/ES2214424T3/es not_active Expired - Lifetime
- 2001-05-08 SK SK1588-2002A patent/SK15882002A3/sk unknown
- 2001-05-08 EP EP01940416A patent/EP1280799B1/de not_active Expired - Lifetime
- 2001-05-08 PL PL01358204A patent/PL358204A1/xx unknown
- 2001-05-08 TR TR2004/00912T patent/TR200400912T4/xx unknown
- 2001-05-08 AU AU7400101A patent/AU7400101A/xx active Pending
- 2001-05-08 DE DE50101364T patent/DE50101364D1/de not_active Expired - Fee Related
- 2001-05-08 NZ NZ521700A patent/NZ521700A/en unknown
- 2001-05-08 EE EEP200200625A patent/EE04938B1/et not_active IP Right Cessation
- 2001-05-08 AU AU2001274001A patent/AU2001274001B2/en not_active Ceased
- 2001-05-08 CN CNB018091369A patent/CN1237062C/zh not_active Expired - Fee Related
- 2001-05-08 DK DK01940416T patent/DK1280799T3/da active
- 2001-05-08 JP JP2001582320A patent/JP2003532725A/ja active Pending
- 2001-05-08 WO PCT/EP2001/005214 patent/WO2001085719A1/de not_active Ceased
- 2001-05-08 HR HR20020977A patent/HRP20020977B1/xx not_active IP Right Cessation
- 2001-05-08 RU RU2002131887/04A patent/RU2264399C2/ru not_active IP Right Cessation
- 2001-08-05 UA UA2002129865A patent/UA73187C2/uk unknown
2002
- 2002-10-31 IL IL152578A patent/IL152578A/en not_active IP Right Cessation
- 2002-11-08 NO NO20025358A patent/NO323541B1/no unknown
- 2002-11-08 BG BG107261A patent/BG107261A/bg unknown
- 2002-12-05 ZA ZA200209896A patent/ZA200209896B/en unknown
2005
- 2005-09-06 US US11/218,423 patent/US20060014747A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1237062C (zh)	2006-01-18
ES2214424T3 (es)	2004-09-16
HRP20020977A2 (en)	2005-02-28
PT1280799E (pt)	2004-06-30
EE04938B1 (et)	2007-12-17
BR0110621A (pt)	2003-03-25
JP2003532725A (ja)	2003-11-05
NZ521700A (en)	2005-09-30
CA2407852A1 (en)	2001-11-15
MXPA02010915A (es)	2003-07-14
WO2001085719A9 (de)	2001-12-27
US7081468B2 (en)	2006-07-25
US20060014747A1 (en)	2006-01-19
DE10023486C1 (de)	2002-03-14
HRP20020977B1 (hr)	2008-05-31
KR20020094024A (ko)	2002-12-16
NO20025358L (no)	2002-11-08
YU82702A (sh)	2006-05-25
US20040102441A1 (en)	2004-05-27
NO20025358D0 (no)	2002-11-08
AU7400101A (en)	2001-11-20
TR200400912T4 (tr)	2004-07-21
EP1280799A1 (de)	2003-02-05
BG107261A (bg)	2003-06-30
PL358204A1 (en)	2004-08-09
IL152578A (en)	2008-11-03
CN1427837A (zh)	2003-07-02
NO323541B1 (no)	2007-06-11
SK15882002A3 (sk)	2003-08-05
ZA200209896B (en)	2004-03-05
UA73187C2 (en)	2005-06-15
EP1280799B1 (de)	2004-01-21
WO2001085719A1 (de)	2001-11-15
HUP0301954A2 (hu)	2003-09-29
DE50101364D1 (de)	2004-02-26
AU2001274001B2 (en)	2007-01-18
CZ20023677A3 (cs)	2003-02-12
IL152578A0 (en)	2003-05-29
DK1280799T3 (da)	2004-05-10
ATE258174T1 (de)	2004-02-15
HK1056728A1 (en)	2004-02-27
RU2264399C2 (ru)	2005-11-20

Legal Events

Date	Code	Title	Description
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2010-02-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20090508

Publication	Publication Date	Title
EE04938B1 (et)	2007-12-17	Orto-asendatud antraniilhappeamiidid ja nende kasutamine ravimitena
EA200100524A1 (ru)	2002-02-28	Амиды антраниловой кислоты и их применение в качестве лекарственных средств
PL361341A1 (pl)	2004-10-04	Nowa kompozycja farmaceutyczna
DK1289517T3 (da)	2006-04-03	Farmaceutiske sammensætninger indeholdende cannabidiolderivater
CY1108932T1 (el)	2014-07-02	Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
ATE191468T1 (de)	2000-04-15	Metalloproteinase inhibitoren
NZ521681A (en)	2006-03-31	Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
CY1110521T1 (el)	2015-04-29	Υποκατεστημενα ινδολια για τη διαμορφωση της nfkb-ενεργοτητας
UY27455A1 (es)	2003-04-30	Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
BR0314797A (pt)	2005-07-26	Derivados da pirimidineamida e o uso dos mesmos
NO20023551D0 (no)	2002-07-25	Ibuprofen-inneholdende aktivt middel-preparat
HUP0200152A2 (hu)	2002-05-29	KQT1 csatornák gátlóinak alkalmazása parazita férgek és ektoparaziták által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
BR0116653A (pt)	2004-02-17	Medicamento contendo uma poliamina como substância ativa
NO20020914L (no)	2002-04-26	Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
SE0004827D0 (sv)	2000-12-22	Therapeutic compounds
DK1232173T3 (da)	2003-09-29	Nye fusidinsyrederivater
SE0300535D0 (sv)	2003-02-28	Treatment of burns
ATE334675T1 (de)	2006-08-15	Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole
AR006760A1 (es)	1999-09-29	Compuesto 2-(3,5-difluorfenil)-3-4(metilsulfonil)fenil-2- ciclopenten-1- ona, util como inhibidor de cox-2, composiciones farmaceuticas y uso del mismopara la fabricación de un medicamento
UA41558A (uk)	2001-09-17	Лікарський засіб для лікування ран "поліфен"
FI965153A0 (fi)	1996-12-20	Metalloproteinaasi-inhibiittorit
TH48054A3 (th)	2001-11-05	วิธีการรักษาอาธีโรสเคลอโรซิส โดยใช้ตัวยับยั้ง aP2 และสิ่งผสมรวม
SE0401716D0 (sv)	2004-07-02	New compounds